Make a ppt on MI ...with proper images and flowchart and for medicine department seminar purpose
myocardial infarction pathophysiology ECG changes STEMI NSTEMI management 2024 guidelines images
STEMI management flowchart algorithm 2025 ACC AHA guidelines primary PCI fibrinolysis
Myocardial Infarction Seminar
Presentation · PPTX
| # | Slide | Highlights |
|---|---|---|
| 1 | Title | Deep navy + crimson design, department branding |
| 2 | Agenda | 15-topic numbered outline with colour-coded columns |
| 3 | Epidemiology | 4 stat cards (9M deaths, 500K STEMI/yr) + risk factor grid |
| 4 | Pathophysiology | Step-by-step plaque rupture cascade + Robbins textbook images (coronary thrombosis + wavefront necrosis diagram) |
| 5 | Universal Definition | All 6 Types of MI (4th Universal Definition 2018) in card layout |
| 6 | Clinical Presentation | Typical vs Atypical/Silent MI side-by-side; "time is myocardium" banner |
| 7 | ECG Changes | Criteria table + localisation grid (anterior/inferior/lateral/posterior/RV) |
| 8 | Biomarkers | hsTroponin, CK-MB, Myoglobin, LDH cards with rise/peak/normalise times + 0h/1h protocol |
| 9 | Imaging | Echo, Angiography, CMR/CTCA cards |
| 10 | Risk Scores | Full TIMI (7 items) vs GRACE (8 variables) with mortality thresholds |
| 11 | STEMI Flowchart | Visual algorithm: D2B ≤90 min, PCI vs fibrinolysis decision, immediate meds, post-PCI regimen |
| 12 | NSTE-ACS Flowchart | 3-tier risk stratification (very-high/high/low) with invasive timing targets |
| 13 | Pharmacotherapy | 4 drug category cards: antiplatelets, anticoagulants, acute agents, long-term secondary prevention |
| 14 | Complications | Timeline columns: immediate/early/late/chronic |
| 15 | Secondary Prevention | 4 pillars: medications, lifestyle, monitoring, targets |
| 16 | OMI Paradigm | STEMI vs OMI comparison + de Winter, Wellens, Sgarbossa explained |
| 17 | Pathology Images | Coronary atherosclerosis + wavefront necrosis (Robbins Pathology) with captions |
| 18 | Killip Classification | 4 class cards with mortality data (5–70%) |
| 19 | Take-Home Messages | 8 numbered key points |
| 20 | References | 8 cited sources including 2025 ACC/AHA guidelines (PMID: 40014670) |